Tag:
Bristol-Myers Squbb
Latest Headlines
Latest Headlines
Bristol-Myers starts Orencia manufacturing at new plant
Five years in the making and a year in testing, Bristol-Myers Squibb ($BMY) has now been given the go-ahead by the FDA to begin manufacturing at a new plant in Devens, MA.
MA anticipates bioprocess job increase
Massachusetts expects a rise in biomanufacturing employment in the next year, a surprising bright spot given the state's strong orientation toward bio R&D. Both Bristol-Myers Squibb ( $BMY ) and
BMS streamlines data matrix coding
Bristol-Myers Squibb has tapped auto-ID solutions provider Zetes for data matrix coding at a production facility in Agen, France. BMS now has 25 coding machines integrated into existing packaging
Nader uses pharma to assail offshore outsourcing
Long-time consumer advocate and former presidential candidate Ralph Nader singles out the pharma industry as he rails against the migration of manufacturing to Asia. And he advocates for more
DHL builds pharma momentum by landing BMS deal
DHL will buy Bristol-Myers Squibb distribution centers in Mount Vernon, IN, as part of a deal in which it assumes U.S. distribution for the drug giant. The carrier will provide operations and
AZ, BMS, Lilly, Pfizer make investor's cut
Investor Osman Gulseven finds that of hundreds of healthcare companies listed on the New York Stock Exchange, only four fit his investment objective of high profitability, substantial dividends and
BMS, Pfizer offload logistics to willing shippers
Shipping specialist UPS has a pharma logistics vision much like that of rival DHL: offload drugmakers of non-core ops tasks; assume as much of that responsibility as possible. The idea is also
BMS offloads U.S. distribution to Exel
Third-party logistics provider Exel will provide U.S. distribution for Bristol-Myers Squibb. To get the deal rolling, the drug giant has sold distribution centers in Mount Vernon, IN, to the service
Constantino defies Cramer on pharma stocks: Buy
Mad Money host Jim Cramer has not gotten the last word on his recent advice to investors to sell their big pharma stocks. Seeking Alpha contributor Frank Constantino says if investors shift to
FDA defines "fix zone" for BMS aseptic fill violations
Promising daily monitoring of plant workers' aseptic procedures was not enough to satisfy the FDA that Bristol-Myers Squibb has the persistent problem resolved. "Please provide more information on
